|Year : 2008 | Volume
| Issue : 3 | Page : 228-232
Existence of proviral porcine endogenous retrovirus in fresh and decellularised porcine tissues
S Prabha, S Verghese
Department of Microbiology, International Centre for Cardio Thoracic and Vascular Diseases, Frontier Lifeline Pvt Ltd, Dr. K.M. Cherian Heart Foundation, R-30-C, Ambattur Industrial Estate Road, Chennai - 600 101, India
|Date of Submission||05-Jan-2008|
|Date of Acceptance||19-Feb-2008|
Department of Microbiology, International Centre for Cardio Thoracic and Vascular Diseases, Frontier Lifeline Pvt Ltd, Dr. K.M. Cherian Heart Foundation, R-30-C, Ambattur Industrial Estate Road, Chennai - 600 101
Source of Support: None, Conflict of Interest: None
Purpose: Swine are expected to be utilized as xenograft donors for both whole organ and cellular transplantation. A major concern in using porcine organs for transplantation is the potential of transmission of porcine endogenous retrovirus (PERV). Tissue-engineered or decellularised heart valves have already been implanted in humans and have been marketed by certain companies after Food and Drug Administration (FDA) approval. The aim of this study was to examine the existence of porcine endogenous retrovirus (PERV) in fresh and decellularised porcine tissues. Methods: Porcine tissues (both fresh and decellularised) were analysed using validated assays specific for PERV: polymerase chain reaction (PCR), reverse transcriptase polymerase chain reaction (RT-PCR). Results: PERV specific GAG sequences were found in the porcine heart tissue samples using PCR for DNA and RT- PCR for RNA. All tissue samples (both fresh and treated tissues) like aortic valve, pulmonary valve and heart muscle showed the presence of PERV DNA. RT PCR for PERV was positive in all fresh tissues and was found to be negative in decellularised treated tissues. Conclusions: PCR is a rapid, specific test for the detection of PERV virus in xenografts. These findings have demonstrated that the presence of proviral DNA form of PERV in porcine tissues needs to be carefully considered when the infectious disease potential of xenotransplantation is being assessed.
Keywords: Decellularised tissues, porcine endogenous retro virus (PERV), xenograft
|How to cite this article:|
Prabha S, Verghese S. Existence of proviral porcine endogenous retrovirus in fresh and decellularised porcine tissues. Indian J Med Microbiol 2008;26:228-32
|How to cite this URL:|
Prabha S, Verghese S. Existence of proviral porcine endogenous retrovirus in fresh and decellularised porcine tissues. Indian J Med Microbiol [serial online] 2008 [cited 2019 Jun 26];26:228-32. Available from: http://www.ijmm.org/text.asp?2008/26/3/228/42032
Among all species analysed, the domestic pig seems to be the most appropriate organ donor for xenotransplantation which offers chances to alleviate the shortage of human donor organs. Porcine endogenous retroviruses (PERVs) are present in genomes of all pigs and are capable of infecting human cells in vitro thus posing a serious threat for xenotransplantation procedures. The existence of porcine endogenous retrovirus (PERV), which are transmitted  and of porcine DNA viruses that can persist without symptoms in their natural host (e.g., herpes viruses)  strengthened objections to the clinical use of pig xenografts due to the possible development of xenozoonosis. PERV display approximately 50 proviral integration sites in the pig genome.  Virions observed in cell lines are morphologically related to C-type viruses. Genetically, three classes of PERV (class A, B, and C), which differ in their env genes, are known. Recent reports demonstrated that PERV which are released from different pig cell lines are able to infect human cells in vitro.  In a retrospective study, no cross - species transmission of PERV in 160 patients treated with pig tissue was observed.  The majority of porcine pathogens can be removed by keeping animals in specific pathogen free conditions. However, these methods do not eliminate those viruses transmitted within the genome, in particular, PERV which has been reproducibly shown to infect human cells in vitro . However, Specke et al demonstrated that, despite in vitro infection of cell lines derived from several species with PERV, none of the corresponding animal models tested showed evidence of PERV infection, regardless of the method of infection or the source of virus used.  Nevertheless, the threat of zoonotic potential in vivo has raised concerns about the presence of endogenous retrovirus sequences in the pig genome.
Donor heart valves or animal-derived valves depleted of cellular antigens can be used as a scaffold material. Removing the cellular components results in a material composed of essentially extracellular matrix proteins that can serve as an intrinsic template for cell attachment. Examples of decellularisation techniques are freeze-drying,  treatment with trypsin/EDTA,  detergent treatment  and multi-step enzymatic procedures. To remove any residual DNA and RNA from the matrix, nuclease digestion steps are desirable.  The maintenance of mechanical properties depends on the decellularisation method used  and on the degree of cross-linking, which stabilises the collagen structure but decreases the ability of tissue in growth. Decellularised porcine scaffolds have been successfully used for cardiovascular tissue engineering. The use of xenograft and allograft tissue as part of bioprosthetic vascular devices such as heart valves and vascular grafts has long been the focus of research. The use of these natural biomaterials has typically required chemical or physical pretreatment aimed at preserving the tissue by enhancing the resistance of the material to enzymatic or chemical degradation, reducing the immunogenicity of the material, and sterilising the tissue.
Multiple cross linking techniques have been explored in an attempt to find the ideal procedure to stabilise the collagen - based structure of the tissue while maintaining its mechanical integrity and natural compliance. In addition to the cross linking techniques, decellularisation approaches may reduce host immune response to bioprosthetics and generate natural biomaterials for use in cell seeding and tissue engineering applications. Natural derived materials offer many mechanical, chemical and biological advantages over synthetic materials and thus hold tremendous potential for use in tissue engineering therapies. In view of the significance of PERV for xenotransplantation, we investigated the presence or absence of porcine endogenous retrovirus in decellularised tissues.
| ~ Materials and Methods|| |
The cell line used in this study PK-15 (Porcine Kidney Epithelial Cell Line) was obtained from the national centre for cell science (NCCS), Pune. This cell line contains PERV virus which is spontaneously released in the tissue culture supernatant. The cell line was maintained in minimum essential medium (Gibco) supplemented with 10% foetal bovine serum, 1 mM sodium pyruvate, 1% non essential aminoacids, 100U of penicillin per mL and 100 μg of streptomycin per mL.
Porcine tissue was harvested and stored immediately in Hank's balance salt solution (HBSS, HiMedia) at 4°C for further processing. Tissue processing in our study was performed by two different procedures in a sequential manner. Detergents like 1% DCA and 1% triton ×100 (with enzymatic digestion) were used separately.
Porcine tissues were placed in 1% sodium deoxycholate (DCA, Himedia) for 50 hours followed by enzymatic treatment (DNase and RNase, Gene I) for 24 hours. Another lot of tissues was placed in 1% triton ×100 (Himedia) and 0.2% ethylenediaminetetraacetic acid (EDTA) in Dulbecco's PBS (Himedia) for 50 hours followed by enzymatic digestion for 24 hours. In order to standardise the procedure, the detergents used as well as the enzymatic digestions were made to vary in the concentration along with variation in the time period of immersion of the concerned tissues in these chemicals. This procedure was executed under continuous shaking in a shaker. In both the procedures, decellularisation was followed by collagen cross-linking and sterilisation using 4% and later 10% formalin in stages for 15-24 hours. Heparin treatment was used overnight which prevents blood protein seepage in the decellularised matrix, as it conjugates with the collagen through various receptors. The processed tissues were finally preserved in 70% alcohol.
Sample preparation for PCR analysis
Porcine kidney epithelial cell line (PK-15) supernatant, used as controls in the PCR and RT-PCR analysis, was lysed and stored frozen at −20ºC. Total cellular DNA was extracted from decellularised porcine tissues and also from fresh untreated porcine tissues using the Qiagen Mini preparation kit.
PERV proviral PCR assay
PCR assay for PERV sequences which targeted conserved 187 bp GAG sequences, was performed.  The primers PRE TF 1, 5' CGG CAA GAG AAG AAT TTG ACT AAG ATC 3' and PRE TR 1, 5'CAG TTC CTT GCC CAG TGT CCT CTT 3' (Quiagen) were used to amplify a 187 bp GAG sequences. Negative amplification controls for each assay included water and a normal human PBL lysate obtained by ficoll-hypaque centrifugation of EDTA-preserved whole blood. PCR was performed with standard conditions of 1 minute at 94ºC, 1 minute at 55ºC, and 1 minute at 72ºC for 35 cycles by using reaction buffer (10mM Tris Hcl, PH 8.3, 50mM kcl, 1.5mM Mgcl2), 2.5U Taq polymerase, 1.25mM of each deoxy nucleoside triphosphate (dNTP), [Quiagen kit] and 100ng of each oligoprimer. Ten microliters of the PCR products were electrophoresed on a 1.8% agarose gel. All the PCR assays were performed following recommended precautions to prevent contamination.
Detection of PERV gag sequences in tissue by RT - PCR:
PERV RNA sequences in decellularised and fresh porcine tissues were determined by using RT - PCR. The assay was standardised on PERV present in tissue culture supernatants from the PK - 15 cell lines.  RNA was extracted from the samples using Ultra Clean Tissue RNA kit (Mobio Laboratories).Briefly, RNA extracted from tissues was treated with 10 U of RNase free DNase and reverse transcribed using the GAG antisense primer (PRETRI). PCR amplification was performed using the GAG sense primer (PRETFI), and the amplified product was detected as for PERV proviral analysis. Reaction volumes of 50 µL containing 100 ng of PRETRI primer, RT buffer (50 mM Kcl, 10 mM Mgcl 2 , 50 mM Tris Hcl, PH: 8.3), 1.25 mM of each dNTP, 7 U of RNase inhibitor, and 50 U of murine leukemia virus Reverse Transcriptase (Mobio laboratories, CA). RT conditions consisted of 5 minutes at 50ºC, 60 minutes at 55ºCand 10 minutes at 60ºC.
PCR reaction mix of 50 µL containing 100ng of PRE TFI primer, 100ng of PRETRI primer, 1× PCR reaction buffer and 2.5U of Taq was added to each RT reaction tube. PCR amplification was performed as described above, and the amplified product was detected as for PERV proviral analysis. Control RT-PCR reactions that received no RT were included for each test run to confirm that a positive result was due to the presence of PERV RNA and was not the result of combination with residual PERV genomic DNA.
| ~ Results|| |
Representative PCR test results of PERV DNA in untreated fresh porcine tissue and treated decellularised tissues are shown in [Figure 1A, B]. DNA extracted from tissue samples was screened by PCR for the detection of GAG gene sequences. Thus PERV proviral PCR assay detected the presence of PERV DNA in all the 50 treated and untreated porcine tissue samples tested.
[Figure 2] shows the representative RT PCR test results from untreated fresh and decellularised treated porcine tissue samples. The RT PCR assay detected presence of PERV RNA in fresh tissues (20/25) and the absence of PERV RNA virions in all the 25 decellularised treated tissue samples. Results of PCR and RT-PCR are summarised in the table.
| ~ Discussion|| |
Endogenous retroviruses (ERV) are remnants of ancestral retroviral infections that have integrated into the germline DNA as a proviral genome, which is vertically transmitted from parent to offspring. Porcine endogenous retroviruses (PERV) may be present in all organs, as multiple copies of PERV can be integrated into germ-line DNA. New and more infectious groups of PERV are being identified, as well as their capacity to infect various types of human cells in vitro .  Although PERV are normally non-pathogenic to their natural host, they have been shown to propagate efficiently and can cause disease if they cross species barriers. Transmission of PERV by the porcine scaffold to the xenogenic host has been considered as a possible limitation of this concept.
The described PCR based assays can be used to screen porcine tissues for PERV DNA and RNA sequences. The PERV assays were designed with conserved PERV oligomers to allow the detection of all known PERV variants. We have developed polymerase chain reaction (PCR) assays to detect proviral PERV GAG sequences by using specific primers. All these PCR assays gave positive results for proviral DNA on porcine tissues in all fresh and decellularised treated tissues. The provirus usually survives as part of the host genome rather than as an infectious agent. Over evolutionary time periods, most of these proviruses acquire mutations so that, with few exceptions, they become defective and incapable of producing protein. The safety of porcine tissue for guided tissue regeneration as well as for xenotransplantation has been questioned recently by Patience and Wilson who demonstrated that PERV is capable of infecting human cell lines in vitro . ,
In this study, we also described transcriptionally active PERV by GAG RT-PCR, in treated and untreated porcine tissues. Since proviral DNA load does not necessarily correlate with viral RNA load we investigated whether the intact proviruses were dormant or biologically active. Our method included DNase pretreatment of RNA extracts, which was necessary to remove any residual PERV DNA that may originate from porcine cells. In addition, we included a control PCR reaction without RT to confirm that the positive RT PCR results in untreated fresh porcine tissues were due to PERV RNA alone. Negative test results seen in RT PCR with untreated fresh samples suggest the inability of the provirus to express functional viral RNA in porcine tissues. Previous studies have demonstrated PERV RNA transcripts in cellular RNA from various pig tissues. ,,
Furthermore, we did not detect any RNA particles in treated porcine matrix. As the tissues are decellularised, presence of live viruses is unlikely. Retroviruses in porcine tissues were the major concerns and the formaldehyde treatment used in both the procedures removes the chance of any microbial infection. Walles et al, demonstrated that after chemical decellularisation of porcine tissue, up to 2% of native DNA is still detectable within the matrix.  Zeltinger et al, in his study observed residual cell remnants after chemical decellularisation of porcine heart valves. 
In conclusion, although the presence of PERV DNA was detectable, PERV RNA sequences were absent in decellularised tissues. In contrast, complete cell removal was not achieved by the decellularisation procedure developed and so the PERV proviral DNA was still detectable in decellularised tissues. Whether chemical decellularisation of porcine tissue used for tissue engineering can prevent PERV-transfection has not been delineated so far. The risk of trans species retroviral infections should not be underestimated, since HIV as another harmless animal retrovirus may cause severe disease in man.
The objective of this study was to demonstrate the presence of PERV in heart valve tissue and to study the effects of decellularisation procedures on PERV proviral DNA and RNA. However, further research is needed to clarify whether these decellularised porcine vascular scaffolds can cause cross-species transmission of PERV in transplant patients
| ~ References|| |
|1.||Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282-6. [PUBMED] |
|2.||Ehlers B, Ulrich S, Goltz M. Detection of two novel porcine Herpesviruses with high similarity to Gammaherpesvirus. J Gen Virol 1999;80:971-8. [PUBMED] [FULLTEXT]|
|3.||Akiyoshi DE, Denaro M, Zhu H, Greenstein JL, Banerjee PT, Fishman JA. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998;72:4503-7. |
|4.||Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Letissier P, et al . Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998;72:9986-91. |
|5.||Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, et al . Search for cross-species transmission of porcine endogenous retrovirus in patients treated with liver pig tissue. Science 1999;285:1236-41. [PUBMED] [FULLTEXT]|
|6.||Specke V, Rubant S, Denner J. Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 2001;285:177-80. [PUBMED] [FULLTEXT]|
|7.||Curtil A, Pegg DE, Wilson A. Repopulation of freeze-dried porcine valves with human fibroblasts and endothelial cells. J Heart Valve Dis 1997;6:296-306. |
|8.||Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, et al . Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits. Circulation 2000;102:III50-5. [PUBMED] [FULLTEXT]|
|9.||Bertiplaglia B, Ortolani F, Petrelli L, Gerosa G, Spina M, Pauletto P, et al . Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: The VESALIO project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thorac Surg 2003;75:1274-82. |
|10.||Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, et al . Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60:S513-6. [PUBMED] |
|11.||Switzer WM, Shanmugam V, Chapman L, Heneine W. Polymerase Chain Reaction assays for the diagnosis of infection with the Porcine Endogenous Retrovirus and the detection of pig cells in human and non human recipients of pig xenografts. Transplantation 1999;68:183-8. [PUBMED] [FULLTEXT]|
|12.||Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998;72:3082-7. [PUBMED] [FULLTEXT]|
|13.||Le Tissier P, Stoye JP, Yasuhiro Y, Patience C, Weiss RA. Two sets of human-tropic pig retrovirus. Nature 1997;389: 681. |
|14.||Walles T, Cebotari S, Sorrentino S. Cardiovascular tissue engineering: Importance of scaffold matrix composition and scaffold thickness. J Am Coll Cardiol 2002;39:198B. |
|15.||Zeltinger J, Landeen LK, Alexander HG, Kidd ID, Sibanda B. Development and characterisation of tissue-engineered aortic valves. Tissue Engg 2001;7:9-22. |
[Figure 1A, B], [Figure 2]
|This article has been cited by|
||Porcine Endogenous Retroviruses in Xenotransplantation—Molecular Aspects
| ||Magdalena Kimsa,Barbara Strzalka-Mrozik,Malgorzata Kimsa,Joanna Gola,Peter Nicholson,Krzysztof Lopata,Urszula Mazurek |
| ||Viruses. 2014; 6(5): 2062 |
|[Pubmed] | [DOI]|
||Preparation of immunogen-reduced and biocompatible extracellular matrices from porcine liver
| ||Kyung-Mee Park, Sung-Min Park, Se-Ran Yang, Seok-Ho Hong, Heung-Myong Woo |
| ||Journal of Bioscience and Bioengineering. 2013; 115(2): 207 |
|[VIEW] | [DOI]|
||Xenotransplantation literature update May-August, 2008
| ||Schneider, M.K.J., Seebach, J.D. |
| ||Xenotransplantation. 2008; 15(5): 344-351 |
||Xenotransplantation literature update May-August, 2008
| ||Mårten K. J. Schneider,Jörg D. Seebach |
| ||Xenotransplantation. 2008; 15(5): 344 |
|[Pubmed] | [DOI]|